Prostatic Size Reduction Following of Leuprorelin Acetate — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prostatic Size Reduction Following of Leuprorelin Acetate — Stella

Recruiting

Back to Prostate Cancer Adenocarcinoma trials

Trial locations(1 site)

Spain

Hospital de Terrassa, Terrassa, Barcelona

Key details

Sponsor

Consorci Sanitari de Terrassa

Enrollment target

~40 participants

Started

February 2024

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 95 Years

Sex

Male only

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov